Basit öğe kaydını göster

Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)

dc.contributor.authorYildiz, I.
dc.contributor.authorEkenel, M.
dc.contributor.authorSen, F.
dc.contributor.authorKilic, L.
dc.contributor.authorKeskin, S.
dc.contributor.authorAydogan, F.
dc.contributor.authorDisci, Rian
dc.contributor.authorSaglam, S.
dc.contributor.authorSakar, B.
dc.contributor.authorAykan, F.
dc.date.accessioned2021-03-03T09:27:10Z
dc.date.available2021-03-03T09:27:10Z
dc.date.issued2013
dc.identifier.citationKeskin S., Yildiz I., Sen F., Aydogan F., Kilic L., Ekenel M., Saglam S., Sakar B., Disci R., Aykan F., "Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)", CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.15, sa.5, ss.403-408, 2013
dc.identifier.issn1699-048X
dc.identifier.otherav_1d054fd2-ad25-45ff-b217-5351b4547602
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/24728
dc.identifier.urihttps://doi.org/10.1007/s12094-012-0942-8
dc.description.abstractThe aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy-na < ve AGC patients.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleModified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)
dc.typeMakale
dc.relation.journalCLINICAL & TRANSLATIONAL ONCOLOGY
dc.contributor.departmentİstanbul Bilim Üniversitesi , ,
dc.identifier.volume15
dc.identifier.issue5
dc.identifier.startpage403
dc.identifier.endpage408
dc.contributor.firstauthorID12234


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster